Microplastics, Nanoplastics and the Heart: Emerging Human Data Link Environmental Particles to Cardiovascular Risk
Highlight
– Multiple prospective human studies report detectable microplastics and nanoplastics (MNPs) in coronary blood, cardiopulmonary-bypass (CPB)–exposed blood, and carotid atheromas.
– MNP presence correlates with local and systemic inflammatory markers and with higher risk of major adverse cardiovascular events (MACE) in observational cohorts.
– Findings are biologically plausible given preclinical evidence but are subject to potential contamination, methodological heterogeneity, and residual confounding; causality remains unproven.
Study background and disease burden
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.